Discover insights into the Global Cell & Gene Therapy Drug Delivery Devices Market set to grow at CAGR of around 14% from 2023-28.
Latest Market Study report by MarkNtel Advisors: Leading market research company, Title “Global Cell & Gene Therapy Drug Delivery Devices Market– By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML)), By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles)” and other forecast 2023-28”.
This thorough report takes a close look at the industry, covering important areas like the Cell & Gene Therapy Drug Delivery Devices Market Size, how much it’s growing, its development, and the top companies involved. It explores what’s pushing the market forward, using data from the past, present, and future, as well as new trends, updates in technology, key insights, recent changes, potential challenges, and other factors that will impact the industry’s future direction.
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”
Link to Download Free Sample of the Report – https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html
Cell & Gene Therapy Drug Delivery Devices Market Driver:
The factors that are projected to drive the market in the coming years include the following:
- Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
- Mounting prevalence of genetic disorders & chronic diseases
- An increasing number of FDA approvals for cell & gene therapies & their clinical trials.
Cell & Gene Therapy Drug Delivery Devices Industry Segmentation:
By Product Type
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Size 1.0 ML, 31-Gauge Needle
- Size 0.5 ML, 22-Gauge Needle
- Pre-Filled Syringe
- Size 1.0 ML, 22-26 Gauge Needle
- Size 4.0 ML, 22-26 Gauge Needle
- Infusion Bags
- Infusion Bags (Size 10 ML to 50 ML)
- Infusion Bags (Size 68 ML)
- Infusion Bags (Size 60 ML)
- Infusion Bags (Size Up to 65 ML)
By Technology
- Microchip Technology
- Nano-Technology
- Lipid Nanoparticles
By Commercialized Drugs
- Luxturna
- Kymriah
- Yescarta
- Zolgensma
- Provenge
- Strimvelis
By End-User
- Pharmaceuticals & Biotechnology Company
- Academic & Research Institute
- Hospitals & Clinics
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Dividing the Cell & Gene Therapy Drug Delivery Devices market into various sections gives a brief snapshot. It aids businesses in grasping customer preferences and their locations. By segmenting the market into smaller categories based on buying behaviors and geography, companies can enhance their business tactics. This overview provides a simple roadmap to comprehend the market better.
Click to See Our In-Depth Analysis Report [Include Content +TOC] – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html
Competitor Insight – Leading Global Cell & Gene Therapy Drug Delivery Devices Market Player
- Amgen Inc.
- Bausch & Lomb Incorporated
- Becton, Dickinson and Company
- Bluebird bio Inc.
- Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
- Dendreon Pharmaceuticals LLC
- Helixmith Co. Ltd (ViroMed Co., Ltd)
- Human Stem Cells Institute
- Kite Pharma Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- Orchard Therapeutics plc.
- Pfizer Inc.
- Renova Therapeutics
- Spark Therapeutics Inc.
- uniQure N.V.
- Vericel Corporation
In this market competitor analysis section, we assess the performance of various companies relative to each other. We analyze their strong points and areas for improvement to grasp who is excelling and why. This enables us to discern which strategies are effective and what adjustments may be necessary to maintain competitiveness.
If you require specific details not currently covered in the report, we will gladly provide them to you as part of our customization services. Please click the and ask our analyst for customized report- https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html
About Us:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, Saudi Arabia, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Media Representative
Email: sales@marknteladvisors.com
Phone: +1 628 895 8081 +91 120 4278433
